Stay updated with breaking news from Emergent Biosolution. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Read more about Confident of meeting US standards: Supplier of Johnson & Johnson vaccine on Business Standard. Johnson and Johnson (J & J) vaccine supplier Emergent BioSolutions said in a statement that it acknowledges it botched a batch of vaccines but is confident of its ability to meet US government safety requirements and standards.The statement comes a
NEW YORK (Reuters) — Johnson & Johnson said on Wednesday it had found a problem with a batch of drug substance for its COVID-19 vaccine, which did not meet quality standards at Emergent Biosolutions' production site in Baltimore, Maryland. The issue was identified and addressed with Emergent and shared with the U.S. Food & Drug Administration, J&J said, adding it was sending more people to supervise manufacturing at the plant. Workers at the plant manufacturing coronavirus shots for J&J and AstraZeneca accidentally conflated the vaccines' ingredients several weeks ago, the New York Times ea...
Millions of Johnson & Johnson COVID-19 vaccines ruined after mix-up Millions of Johnson & Johnson’s single-shot COVID-19 vaccine doses have been lost after an ingredient mix-up, according to a new report. The incident happened at a factory in Baltimore, Maryland, where two different COVID-19 vaccine products are made; the ingredients for the two were accidentally mixed up, resulting in up to 15 million single-shot vaccine doses that must be trashed. The issue happened several weeks ago, The New York Timesreports. The Emergent BioSolutions facility where the vaccines were produced was suppo...
J&J finds problem with COVID vaccine batch; NYTimes says 15 million doses ruined FILE PHOTO: Vials labelled "COVID-19 Coronavirus Vaccine" and sryinge are seen in front of displayed Johnson&Johnson logo in this illustration taken, February 9, 2021. REUTERS/Dado Ruvic/Illustration reuters_tickers This content was published on April 1, 2021 - 02:37 April 1, 2021 - 02:37 (Reuters) -Johnson & Johnson said on Wednesday it had found a problem with a batch of the drug substance for its COVID-19 vaccine being produced by Emergent Biosolutions, and said the batch did not advance to the final fill-and-...
<div class="at-above-post addthis_tool" data-url="https://www.metro.us/jj-finds-problem-with/"></div>(Reuters) -Johnson & Johnson said on Wednesday it had found a problem with a batch of drug substance for its COVID-19 vaccine, which did not meet quality standards at Emergent Biosolutions’ production site in Baltimore, Maryland. The issue was identified and addressed with Emergent and shared with the U.S. Food & Drug Administration, J&J said, […]<!-- AddThis Advanced Settings above via filter on get_the_excerpt --><!-- AddThis A...